Qatar

Medicines regulation and post-market oversight in Qatar are administered by the Ministry of Public Health through the Pharmacy and Drug Control Department. Relevant Arabic official services include خدمة تسجيل المستحضرات الصيدلانية, خدمة الإبلاغ عن الآثار الجانبية للقاحات and خدمة التغييرات على المستحضرات الصيدلانية المسجلة. The reviewed public Ministry pages do not provide a single comprehensive industry-facing pharmacovigilance guideline establishing, for every MAH, a resident QPPV, local PSMF, fixed medicinal-product ICSR timetable, routine PSUR/PBRER schedule or universal RMP requirement. Companies should therefore confirm the current post-authorisation conditions and reporting channel with the Department, maintain a documented safety system and reachable local contact, and promptly escalate serious or unexpected adverse events, product-quality defects, recalls, emerging signals and safety-related variations. The vaccine reporting service should not be described as a general medicinal-product reporting portal. BAUPHARMA supporting resources (operational context only, not national regulatory evidence): Effective Signal Management in Pharmacovigilance.